Pulmonary arterial hypertension exacerbated by ruxolitinib

Andrew T. Low*, Luke Howard, Claire Harrison, Robert M R Tulloh

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)e244-e245
JournalHaematologica
Volume100
Issue number6
DOIs
Publication statusPublished - Jun 2015

Keywords

  • Drug induced pulmonary arterial hypertension
  • JAK inhibitor
  • Myelofibrosis
  • Ruxolitinib

Cite this